Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

SHA:600222 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	403.94	180.04	196.67	311.38	380.55	487.32
Trading Asset Securities	-	80.02	153.3	74.96	285.67	207.46
Cash & Short-Term Investments	403.94	260.05	349.97	386.34	666.22	694.78
Cash Growth	29.12%	-25.69%	-9.41%	-42.01%	-4.11%	20.92%
Accounts Receivable	1,066	1,137	1,056	1,038	744.71	689.25
Other Receivables	51.8	36.38	44.01	51.15	56.44	78.65
Receivables	1,118	1,173	1,100	1,089	801.15	767.89
Inventory	364.82	367.67	455.5	450.49	381.85	348.14
Other Current Assets	111.55	105.35	87.88	105.03	94.49	71.56
Total Current Assets	1,998	1,906	1,993	2,031	1,944	1,882
Property, Plant & Equipment	490.16	501.82	529.65	551.13	539.58	494.09
Long-Term Investments	486.6	526.67	520.38	490.93	825.63	533.76
Goodwill	286.49	286.49	286.49	286.49	286.49	286.49
Other Intangible Assets	49.99	51.17	52.5	48.11	53.1	57.54
Long-Term Deferred Tax Assets	113.67	113.2	94.24	95.38	52.4	47.16
Long-Term Deferred Charges	53.4	52.8	49.81	54.23	35.81	32.98
Other Long-Term Assets	87.15	51.55	50.71	49.08	47.05	54.99
Total Assets	3,566	3,490	3,577	3,607	3,784	3,389
Accounts Payable	311.78	294.89	470.29	548.89	355.65	211.71
Accrued Expenses	13.87	29.23	25.9	32.22	22.45	20.56
Short-Term Debt	695.07	663.42	381.84	404.87	973.58	750.22
Current Portion of Long-Term Debt	237.39	270.07	89.76	4.22	158.74	406.21
Current Portion of Leases	-	46.29	35.35	26.89	-	-
Current Income Taxes Payable	-	1.28	2.53	21.86	3.7	2.98
Current Unearned Revenue	6.62	6.54	11.62	88.26	49.47	61.27
Other Current Liabilities	506	482.79	632.86	598.82	86.09	50.94
Total Current Liabilities	1,771	1,795	1,650	1,726	1,650	1,504
Long-Term Debt	103.02	3.02	183.8	192.8	20.37	136.38
Long-Term Leases	8.1	42.04	89.29	37.14	72.06	31.6
Long-Term Unearned Revenue	2.7	2.78	3.26	1.71	-	-
Long-Term Deferred Tax Liabilities	19.96	21.16	25.36	33.26	132.42	56.96
Other Long-Term Liabilities	30	-	1.62	1.62	131.62	130
Total Liabilities	1,935	1,864	1,953	1,993	2,006	1,859
Common Stock	573.89	573.89	573.89	573.89	573.89	573.89
Additional Paid-In Capital	675.17	675.17	675.17	675.17	588.14	588.14
Retained Earnings	332.66	316.01	281.01	237.46	232.15	235.16
Treasury Stock	-109.8	-101.01	-79.72	-37.66	-48.7	-98.47
Comprehensive Income & Other	106.49	110.67	128.15	121.56	315.04	154.7
Total Common Equity	1,578	1,575	1,578	1,570	1,661	1,453
Minority Interest	52.61	51.51	44.89	43.62	117.13	77.16
Shareholders' Equity	1,631	1,626	1,623	1,614	1,778	1,531
Total Liabilities & Equity	3,566	3,490	3,577	3,607	3,784	3,389
Total Debt	1,044	1,025	780.03	665.92	1,225	1,324
Net Cash (Debt)	-639.64	-764.79	-430.07	-279.58	-558.53	-629.62
Net Cash Per Share	-1.16	-1.37	-0.76	-0.50	-1.00	-1.15
Filing Date Shares Outstanding	546.63	554.67	559.36	566.69	563.04	545.98
Total Common Shares Outstanding	546.63	554.67	559.36	566.69	563.04	545.98
Working Capital	227.33	111.55	342.93	305.21	294.03	378.49
Book Value Per Share	2.89	2.84	2.82	2.77	2.95	2.66
Tangible Book Value	1,242	1,237	1,239	1,236	1,321	1,109
Tangible Book Value Per Share	2.27	2.23	2.22	2.18	2.35	2.03
Buildings	-	556.93	543.26	534.9	520.76	516.81
Machinery	-	361.45	341.92	316.19	281.14	247.95
Construction In Progress	-	29.2	28.9	31.1	33.02	24.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.